These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8637715)
21. Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RAR-dependent gene expression. Yang L; Munoz-Medellin D; Kim HT; Ostrowski J; Reczek P; Brown PH Breast Cancer Res Treat; 1999 Aug; 56(3):277-91. PubMed ID: 10573118 [TBL] [Abstract][Full Text] [Related]
22. Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells. Zhao Z; Zhang ZP; Soprano DR; Soprano KJ Exp Cell Res; 1995 Aug; 219(2):555-61. PubMed ID: 7641808 [TBL] [Abstract][Full Text] [Related]
23. Redox control of retinoic acid receptor activity: a novel mechanism for retinoic acid resistance in melanoma cells. Demary K; Wong L; Liou JS; Faller DV; Spanjaard RA Endocrinology; 2001 Jun; 142(6):2600-5. PubMed ID: 11356710 [TBL] [Abstract][Full Text] [Related]
24. Retinoic acid-receptor activation of SP-B gene transcription in respiratory epithelial cells. Yan C; Ghaffari M; Whitsett JA; Zeng X; Sever Z; Lin S Am J Physiol; 1998 Aug; 275(2):L239-46. PubMed ID: 9700083 [TBL] [Abstract][Full Text] [Related]
25. Analysis of the effects of CRABP I expression on the RA-induced transcription mediated by retinoid receptors. Venepally P; Reddy LG; Sani BP Biochemistry; 1996 Aug; 35(31):9974-82. PubMed ID: 8756459 [TBL] [Abstract][Full Text] [Related]
26. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids. Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993 [TBL] [Abstract][Full Text] [Related]
27. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells. Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055 [TBL] [Abstract][Full Text] [Related]
28. All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use. Giannini F; Maestro R; Vukosavljevic T; Pomponi F; Boiocchi M Int J Cancer; 1997 Jan; 70(2):194-200. PubMed ID: 9009160 [TBL] [Abstract][Full Text] [Related]
29. Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells. Zou CP; Hong WK; Lotan R Differentiation; 1999 Jan; 64(2):123-32. PubMed ID: 10234809 [TBL] [Abstract][Full Text] [Related]
30. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers. Lotan R Anticancer Res; 1996; 16(4C):2415-9. PubMed ID: 8816844 [TBL] [Abstract][Full Text] [Related]
31. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells. Li Y; Hashimoto Y; Agadir A; Kagechika H; Zhang Xk J Biol Chem; 1999 May; 274(22):15360-6. PubMed ID: 10336422 [TBL] [Abstract][Full Text] [Related]
32. Genomic footprinting of retinoic acid regulated promoters in embryonal carcinoma cells. Dey A; Ozato K Methods; 1997 Feb; 11(2):197-204. PubMed ID: 8993032 [TBL] [Abstract][Full Text] [Related]
33. Induction of apoptosis without differentiation by retinoic acid in PLB-985 cells requires the activation of both RAR and RXR. Monczak Y; Trudel M; Lamph WW; Miller WH Blood; 1997 Nov; 90(9):3345-55. PubMed ID: 9345016 [TBL] [Abstract][Full Text] [Related]
34. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Sheikh MS; Shao ZM; Li XS; Ordonez JV; Conley BA; Wu S; Dawson MI; Han QX; Chao WR; Quick T Carcinogenesis; 1995 Oct; 16(10):2477-86. PubMed ID: 7586155 [TBL] [Abstract][Full Text] [Related]
35. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells. Duprez E; Lillehaug JR; Gaub MP; Lanotte M Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786 [TBL] [Abstract][Full Text] [Related]
36. Regulation of RAR beta expression by RAR- and RXR-selective retinoids in human lung cancer cell lines: effect on growth inhibition and apoptosis induction. Li Y; Dawson MI; Agadir A; Lee MO; Jong L; Hobbs PD; Zhang XK Int J Cancer; 1998 Jan; 75(1):88-95. PubMed ID: 9426695 [TBL] [Abstract][Full Text] [Related]
37. Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids. Sheikh MS; Shao ZM; Li XS; Dawson M; Jetten AM; Wu S; Conley BA; Garcia M; Rochefort H; Fontana JA J Biol Chem; 1994 Aug; 269(34):21440-7. PubMed ID: 8063776 [TBL] [Abstract][Full Text] [Related]
38. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines. Kazmi SM; Plante RK; Visconti V; Lau CY Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761 [TBL] [Abstract][Full Text] [Related]
39. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells. de Vos S; Dawson MI; Holden S; Le T; Wang A; Cho SK; Chen DL; Koeffler HP Prostate; 1997 Jul; 32(2):115-21. PubMed ID: 9215399 [TBL] [Abstract][Full Text] [Related]